Life Long Learning Knowledge Assessment Course: Urodynamic Evaluation & Advances in Management of Neurogenic Lower Urinary Tract Dysfunction in Adults: A Case-Based Approach Webcast 037IC (2018)

This comprehenisve and very practical course on adult neurogenic bladder dysfunction is designed for Urology residents, fellows, practicing urologists, and allied health professionals (e.g., nurses and physical therapists) with special interest in Neuro-Urology. Topics covered will include urodynamic evaluation of patients with various neurogenic bladder conditions and an up-to-date review of non-pharmacological, pharmacological, minimally invasive, and reconstructive surgical treatment options. The presentations will be corroborated and supplemented by real clinical cases of the course faculty, providing a unique case based approach to the evaluation and management. Exceptionally clear and instructional urodynamic illustrations of common neurogenic lower urinary tract conditions (CVA, Parkinson's disease, multiple sclerosis, brain tumors, spinal cord injury, myelodysplasia, spinal cord tumors, herniated intervertebral disk, peripheral nerve injury, cauda equina syndrome, conus medullaris syndrome, among others) will be included along with contemporary advances in the management as practiced in 2016-2017 in the light of recent guidelines in the management of adult neurogenic lower urinary tract dysfunction. At the end of the course, participants will become confident and proficient in the urodynamic evaluation and contemporary management of common neurogenic lower urinary tract conditions.

Target Audience

  • Urologists

Learning Objectives

After completing this activity, participants will be able to:

  1. Employ the physics behind each of the modalities of multi-parametric ultrasound.
  2. Identify the potential advantages and limitations of each of the modalities of multi-parametric ultrasound.
  3. Deploy the technology to improve the diagnosis of prostate cancer in appropriately selected populations of patients.
  4. Outline the additional resources and expertise necessary to use the modalities of multi-parametric ultrasound.
  5. Compare the efficacy of multiparametric ultrasound to that of multiparametric MRI.
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
Course opens: 
10/25/2018
Course expires: 
10/25/2021
Price:
$99.00
Rating: 
0

COURSE DIRECTOR

Hari Tunuguntla, MD, MS, MCh: Nothing to disclose

FACULTY

Angelo Gousse, MD: Allergen: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; Caldera: Consultant or Advisor; Precision Medical Devices: Consultant or Advisor, Scientific Study or Trial
Stephen Kraus, MD MS FACS: Laborie: Other; Allergan: Consultant or Advisor; Astellas: Consultant or Advisor, Meeting Participant or Lecturer; InCube: Consultant or Advisor; GTx: Consultant or Advisor

 

Education Council Disclosures

METHOD OF PARTICIPATION: 

Learners will participate in this online educational activity by taking the pretest, viewing the webcast and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.

Estimated time to complete this activity: 2.00 hours

Release Date: October, 2018
Expiration Date: October, 2021

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this enduring activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation

Price

Price:
$99.00
Please login or register to take this course.